is retatrutide a glp-3 (GLP-3) – Y&P Labs NEW GPL 3 | WE

August 11th, 2025: Research Suggests Possible Muscle Weakness Risks from Ozempic A new study from the University of Utah Health raises concerns about potential muscle-related effects of GLP-1 drugs, noting reduced strength in certain muscles despite little change in muscle size

doi: 10.1016/S0140-6736(21)00213-0 [DOI] [PubMed] [Google Scholar] 234

That link does not mean feeling sicker is good, but it hints that benefit and burden can share biology

The most commonly reported adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, which typically diminish over time

Neuroprotective effect of metformin on dopaminergic neurodegeneration and -synuclein aggregation in C

This helps keep people enrolled safe and provides physicians a comprehensive view of risk